Medindia LOGIN REGISTER
Medindia

Triamcinolone Hexacetonide Interaction with other Drugs


Triamcinolone Hexacetonide is an anti-inflammatory (steroidal), prescribed as adjunctive therapy for acute gouty arthritis, acute and subacute bursitis, acute nonspecific tenosynovitis, epicondylitis, rheumatoid arthritis, and synovitis of osteoarthritis.

Triamcinolone Hexacetonide Interaction with 393 drugs. Find out more in the list below:

4-Phenylbutyric Acid


The therapeutic efficacy of Phenylbutyric acid can be decreased when used in combination with Triamcinolone.

Acarbose


The therapeutic efficacy of Acarbose can be decreased when used in combination with Triamcinolone.

Aceclofenac


The risk or severity of adverse effects can be increased when Aceclofenac is combined with Triamcinolone.

Advertisement

Acemetacin


The risk or severity of adverse effects can be increased when Acemetacin is combined with Triamcinolone.

Acetohexamide


The therapeutic efficacy of Acetohexamide can be decreased when used in combination with Triamcinolone.

Acetyl salicylate


The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Triamcinolone.

Advertisement

Adapalene


The risk or severity of adverse effects can be increased when Adapalene is combined with Triamcinolone.

Aldesleukin


Triamcinolone may decrease the antineoplastic activities of Aldesleukin.

Alminoprofen


The risk or severity of adverse effects can be increased when Alminoprofen is combined with Triamcinolone.

Advertisement

Alogliptin


The therapeutic efficacy of Alogliptin can be decreased when used in combination with Triamcinolone.

Aloxiprin


The risk or severity of adverse effects can be increased when Aloxiprin is combined with Triamcinolone.

Aluminum


The bioavailability of Triamcinolone can be decreased when combined with Aluminium.

Aluminum Hydroxide


The bioavailability of Triamcinolone can be decreased when combined with Aluminum hydroxide.

aluminum hydroxide, dried (USP)


The bioavailability of Triamcinolone can be decreased when combined with Aluminum hydroxide.

Aluminum Magnesium Silicate


The bioavailability of Triamcinolone can be decreased when combined with Almasilate.

Ambenonium


The risk or severity of adverse effects can be increased when Triamcinolone is combined with Ambenonium.

Aminosalicylic Acid


The risk or severity of adverse effects can be increased when Aminosalicylic Acid is combined with Triamcinolone.

Amiodarone


The metabolism of Triamcinolone can be decreased when combined with Amiodarone.

Amoxapine


The therapeutic efficacy of Triamcinolone can be decreased when used in combination with Amoxapine.

Amphotericin B


Triamcinolone may increase the hypokalemic activities of Amphotericin B.

amphotericin B liposomal


Triamcinolone may increase the hypokalemic activities of Amphotericin B.

Anhydrous Tacrolimus


Tacrolimus may increase the immunosuppressive activities of Triamcinolone.

Anthrax immune globulin, human


The risk or severity of adverse effects can be increased when Triamcinolone is combined with Anthrax immune globulin human.

Antipyrine


The risk or severity of adverse effects can be increased when Antipyrine is combined with Triamcinolone.

Apalutamide


The serum concentration of Triamcinolone can be decreased when it is combined with Apalutamide.

Apazone


The risk or severity of adverse effects can be increased when Azapropazone is combined with Triamcinolone.

Apremilast


The risk or severity of adverse effects can be increased when Apremilast is combined with Triamcinolone.

Aprepitant


The serum concentration of Triamcinolone can be increased when it is combined with Aprepitant.

Aspirin


The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Triamcinolone.

Atazanavir


The metabolism of Triamcinolone can be decreased when combined with Atazanavir.

Atomoxetine


The metabolism of Triamcinolone can be decreased when combined with Atomoxetine.

Atracurium Besylate


Atracurium besylate may increase the adverse neuromuscular activities of Triamcinolone.

Azelastine


The risk or severity of adverse effects can be increased when Azelastine is combined with Triamcinolone.

Azosemide


Triamcinolone may increase the hypokalemic activities of Azosemide.

Balsalazide


The risk or severity of adverse effects can be increased when Balsalazide is combined with Triamcinolone.

BCG Vaccine


The risk or severity of adverse effects can be increased when Triamcinolone is combined with BCG vaccine.

BCG, Live, Connaught Strain


The risk or severity of adverse effects can be increased when Triamcinolone is combined with Bacillus calmette-guerin substrain connaught live antigen.

BCG, Live, Tice Strain


The risk or severity of adverse effects can be increased when Triamcinolone is combined with Bacillus calmette-guerin substrain tice live antigen.

Bendroflumethiazide


Triamcinolone may increase the hypokalemic activities of Bendroflumethiazide.

Benzoic Acid


The therapeutic efficacy of Benzoic Acid can be decreased when used in combination with Triamcinolone.

Benzydamine


The risk or severity of adverse effects can be increased when Benzydamine is combined with Triamcinolone.

Bismuth Subcitrate


The bioavailability of Triamcinolone can be decreased when combined with Bismuth Subcitrate.

Boceprevir


The metabolism of Triamcinolone can be decreased when combined with Boceprevir.

Bortezomib


The metabolism of Triamcinolone can be decreased when combined with Bortezomib.

Bosentan


The serum concentration of Triamcinolone can be decreased when it is combined with Bosentan.

Bromfenac


The risk or severity of adverse effects can be increased when Bromfenac is combined with Triamcinolone.

Bufexamac


The risk or severity of adverse effects can be increased when Bufexamac is combined with Triamcinolone.

Bumetanide


Triamcinolone may increase the hypokalemic activities of Bumetanide.

Calcitriol


The therapeutic efficacy of Calcitriol can be decreased when used in combination with Triamcinolone.

Calcium Carbonate


The bioavailability of Triamcinolone can be decreased when combined with Calcium Carbonate.

CALCIUM CARBONATE, PRECIPITATED


The bioavailability of Triamcinolone can be decreased when combined with Calcium Carbonate.

Canagliflozin


The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Triamcinolone.

Canagliflozin Anhydrous


The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Triamcinolone.

Capromab Pendetide


Triamcinolone may decrease effectiveness of Capromab pendetide as a diagnostic agent.

Carbamazepine


The metabolism of Triamcinolone can be increased when combined with Carbamazepine.

Carprofen


The risk or severity of adverse effects can be increased when Carprofen is combined with Triamcinolone.

Celecoxib


The risk or severity of adverse effects can be increased when Celecoxib is combined with Triamcinolone.

Ceritinib


The serum concentration of Triamcinolone can be increased when it is combined with Ceritinib.

Chloroquine


The risk or severity of adverse effects can be increased when Chloroquine is combined with Triamcinolone.

Chlorothiazide


Triamcinolone may increase the hypokalemic activities of Chlorothiazide.

Chlorotrianisene


The serum concentration of Triamcinolone can be increased when it is combined with Chlorotrianisene.

Chlorpropamide


The therapeutic efficacy of Chlorpropamide can be decreased when used in combination with Triamcinolone.

Chlorthalidone


Triamcinolone may increase the hypokalemic activities of Chlorthalidone.

Cholestyramine Resin


Cholestyramine can cause a decrease in the absorption of Triamcinolone resulting in a reduced serum concentration and potentially a decrease in efficacy.

Choline Magnesium Trisalicyclate


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Triamcinolone.

Cinoxacin


The risk or severity of adverse effects can be increased when Triamcinolone is combined with Cinoxacin.

Clarithromycin


The metabolism of Triamcinolone can be decreased when combined with Clarithromycin.

Clemastine


The metabolism of Triamcinolone can be decreased when combined with Clemastine.

Clonixin


The risk or severity of adverse effects can be increased when Clonixin is combined with Triamcinolone.

Clotrimazole


The metabolism of Triamcinolone can be decreased when combined with Clotrimazole.

Cobicistat


The metabolism of Triamcinolone can be decreased when combined with Cobicistat.

Colesevelam


Colesevelam can cause a decrease in the absorption of Triamcinolone resulting in a reduced serum concentration and potentially a decrease in efficacy.

Colestipol


Colestipol can cause a decrease in the absorption of Triamcinolone resulting in a reduced serum concentration and potentially a decrease in efficacy.

Conivaptan


The serum concentration of Conivaptan can be increased when it is combined with Triamcinolone.

Corticorelin Ovine


The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Triamcinolone.

Corticorelin Ovine Triflutate


The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Triamcinolone.

Crizotinib


The metabolism of Triamcinolone can be decreased when combined with Crizotinib.

Curcumin


The risk or severity of adverse effects can be increased when Curcumin is combined with Triamcinolone.

Cyclopenthiazide


Triamcinolone may increase the hypokalemic activities of Cyclopenthiazide.

Cyclosporine


The metabolism of Triamcinolone can be decreased when combined with Cyclosporine.

Dabrafenib


The serum concentration of Triamcinolone can be decreased when it is combined with Dabrafenib.

Danazol


Triamcinolone may increase the fluid retaining activities of Danazol.

Darunavir


The metabolism of Triamcinolone can be decreased when combined with Darunavir.

Dasatinib


The serum concentration of Triamcinolone can be increased when it is combined with Dasatinib.

Dasatinib Anhydrous


The serum concentration of Triamcinolone can be increased when it is combined with Dasatinib.

Deferasirox


The serum concentration of Triamcinolone can be decreased when it is combined with Deferasirox.

Delavirdine


The metabolism of Triamcinolone can be decreased when combined with Delavirdine.

Demecarium


The risk or severity of adverse effects can be increased when Triamcinolone is combined with Demecarium.

Denosumab


The risk or severity of adverse effects can be increased when Denosumab is combined with Triamcinolone.

Diclofenac


The risk or severity of adverse effects can be increased when Diclofenac is combined with Triamcinolone.

Dienestrol


The serum concentration of Triamcinolone can be increased when it is combined with Dienestrol.

Diethylstilbestrol


The serum concentration of Triamcinolone can be increased when it is combined with Diethylstilbestrol.

Diflunisal


The risk or severity of adverse effects can be increased when Diflunisal is combined with Triamcinolone.

Dihydroergotamine


The metabolism of Triamcinolone can be decreased when combined with Dihydroergotamine.

Diltiazem


The metabolism of Triamcinolone can be decreased when combined with Diltiazem.

Dipyrone


The risk or severity of adverse effects can be increased when Metamizole is combined with Triamcinolone.

Distigmine


The risk or severity of adverse effects can be increased when Triamcinolone is combined with Distigmine.

Donepezil


The risk or severity of adverse effects can be increased when Triamcinolone is combined with Donepezil.

Doxycycline


The metabolism of Triamcinolone can be decreased when combined with Doxycycline.

Doxycycline Anhydrous


The metabolism of Triamcinolone can be decreased when combined with Doxycycline.

Dronedarone


The metabolism of Triamcinolone can be decreased when combined with Dronedarone.

Droxicam


The risk or severity of adverse effects can be increased when Droxicam is combined with Triamcinolone.

Dulaglutide


The therapeutic efficacy of Dulaglutide can be decreased when used in combination with Triamcinolone.

Echothiophate


The risk or severity of adverse effects can be increased when Triamcinolone is combined with Echothiophate.

Edrophonium


The risk or severity of adverse effects can be increased when Triamcinolone is combined with Edrophonium.

Empagliflozin


The therapeutic efficacy of Empagliflozin can be decreased when used in combination with Triamcinolone.

Enoxacin


The risk or severity of adverse effects can be increased when Triamcinolone is combined with Enoxacin.

Enzalutamide


The serum concentration of Triamcinolone can be decreased when it is combined with Enzalutamide.

Equol, (-)-


The serum concentration of Triamcinolone can be increased when it is combined with Equol.

Erythromycin


The metabolism of Triamcinolone can be decreased when combined with Erythromycin.

Estradiol


The serum concentration of Triamcinolone can be increased when it is combined with Estradiol.

Estradiol acetate


The serum concentration of Triamcinolone can be increased when it is combined with Estradiol acetate.

Estradiol Cypionate


The serum concentration of Triamcinolone can be increased when it is combined with Estradiol cypionate.

Estradiol Valerate


The serum concentration of Triamcinolone can be increased when it is combined with Estradiol valerate.

Estriol


The serum concentration of Triamcinolone can be increased when it is combined with Estriol.

Estrogens, Conjugated (USP)


The serum concentration of Triamcinolone can be increased when it is combined with Conjugated estrogens.

Estrogens, Esterified (USP)


The serum concentration of Triamcinolone can be increased when it is combined with Estrogens, esterified.

Estrone


The serum concentration of Triamcinolone can be increased when it is combined with Estrone.

Etanercept


The risk or severity of adverse effects can be increased when Etanercept is combined with Triamcinolone.

Ethacrynate


Triamcinolone may increase the hypokalemic activities of Etacrynic acid.

Ethacrynic Acid


Triamcinolone may increase the hypokalemic activities of Etacrynic acid.

Ethinyl Estradiol


The serum concentration of Triamcinolone can be increased when it is combined with Ethinyl Estradiol.

Etodolac


The risk or severity of adverse effects can be increased when Etodolac is combined with Triamcinolone.

Etofenamate


The risk or severity of adverse effects can be increased when Etofenamate is combined with Triamcinolone.

Etoricoxib


The risk or severity of adverse effects can be increased when Etoricoxib is combined with Triamcinolone.

Evening primrose oil


The risk or severity of adverse effects can be increased when Evening primrose oil is combined with Triamcinolone.

Exenatide


The therapeutic efficacy of Exenatide can be decreased when used in combination with Triamcinolone.

Felbinac


The risk or severity of adverse effects can be increased when Felbinac is combined with Triamcinolone.

Fenbufen


The risk or severity of adverse effects can be increased when Fenbufen is combined with Triamcinolone.

Fenoprofen


The risk or severity of adverse effects can be increased when Fenoprofen is combined with Triamcinolone.

Ferulic Acid


The risk or severity of adverse effects can be increased when Ferulic acid is combined with Triamcinolone.

Fingolimod


Triamcinolone may increase the immunosuppressive activities of Fingolimod.

Fleroxacin


The risk or severity of adverse effects can be increased when Triamcinolone is combined with Fleroxacin.

Floctafenine


The risk or severity of adverse effects can be increased when Floctafenine is combined with Triamcinolone.

Fluconazole


The metabolism of Triamcinolone can be decreased when combined with Fluconazole.

Flumequine


The risk or severity of adverse effects can be increased when Triamcinolone is combined with Flumequine.

Fluoxymesterone


Triamcinolone may increase the fluid retaining activities of Fluoxymesterone.

Flurbiprofen


The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Triamcinolone.

Fluvoxamine


The metabolism of Triamcinolone can be decreased when combined with Fluvoxamine.

Fosamprenavir


The metabolism of Triamcinolone can be decreased when combined with Fosamprenavir.

Fosaprepitant


The serum concentration of Triamcinolone can be increased when it is combined with Fosaprepitant.

Fosphenytoin


The metabolism of Triamcinolone can be increased when combined with Fosphenytoin.

Furosemide


Triamcinolone may increase the hypokalemic activities of Furosemide.

Fusidate


The serum concentration of Triamcinolone can be increased when it is combined with Fusidic Acid.

Fusidic Acid


The serum concentration of Triamcinolone can be increased when it is combined with Fusidic Acid.

Galantamine


The risk or severity of adverse effects can be increased when Triamcinolone is combined with Galantamine.

Gallamine Triethiodide


The risk or severity of adverse effects can be increased when Triamcinolone is combined with Gallamine Triethiodide.

Gatifloxacin


The risk or severity of adverse effects can be increased when Triamcinolone is combined with Gatifloxacin.

Gatifloxacin Anhydrous


The risk or severity of adverse effects can be increased when Triamcinolone is combined with Gatifloxacin.

Gemifloxacin


The risk or severity of adverse effects can be increased when Triamcinolone is combined with Gemifloxacin.

Gemifloxacin Mesylate


The risk or severity of adverse effects can be increased when Triamcinolone is combined with Gemifloxacin.

Genistein


The serum concentration of Triamcinolone can be increased when it is combined with Genistein.

Ginkgo biloba extract


The risk or severity of adverse effects can be increased when Triamcinolone is combined with Ginkgo biloba.

Glibornuride


The therapeutic efficacy of Glibornuride can be decreased when used in combination with Triamcinolone.

Gliclazide


The therapeutic efficacy of Gliclazide can be decreased when used in combination with Triamcinolone.

Glimepiride


The therapeutic efficacy of Glimepiride can be decreased when used in combination with Triamcinolone.

Glipizide


The therapeutic efficacy of Glipizide can be decreased when used in combination with Triamcinolone.

Gliquidone


The therapeutic efficacy of Gliquidone can be decreased when used in combination with Triamcinolone.

Glyburide


The therapeutic efficacy of Glyburide can be decreased when used in combination with Triamcinolone.

Glycerol Phenylbutyrate


The therapeutic efficacy of Glycerol Phenylbutyrate can be decreased when used in combination with Triamcinolone.

Grepafloxacin


The risk or severity of adverse effects can be increased when Triamcinolone is combined with Grepafloxacin.

Hepatitis A Vaccine, Inactivated


The risk or severity of adverse effects can be increased when Triamcinolone is combined with Hepatitis A Vaccine.

Hepatitis B Surface Antigen Vaccine


The risk or severity of adverse effects can be increased when Triamcinolone is combined with Hepatitis B Vaccine (Recombinant).

Hyaluronidase


The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Triamcinolone.

Hyaluronidase, Ovine


The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Triamcinolone.

Hydrochlorothiazide


Triamcinolone may increase the hypokalemic activities of Hydrochlorothiazide.

Hydroflumethiazide


Triamcinolone may increase the hypokalemic activities of Hydroflumethiazide.

Hydrotalcite


The bioavailability of Triamcinolone can be decreased when combined with Hydrotalcite.

Hypoxis hemerocallidea root extract


The serum concentration of Triamcinolone can be decreased when it is combined with St. John's Wort.

Ibuprofen


The risk or severity of adverse effects can be increased when Ibuprofen is combined with Triamcinolone.

Icatibant


The risk or severity of adverse effects can be increased when Icatibant is combined with Triamcinolone.

Idelalisib


The metabolism of Triamcinolone can be decreased when combined with Idelalisib.

Imatinib


The metabolism of Triamcinolone can be decreased when combined with Imatinib.

Indacaterol


Indacaterol may increase the hypokalemic activities of Triamcinolone.

Indapamide


Triamcinolone may increase the hypokalemic activities of Indapamide.

Indinavir


The metabolism of Triamcinolone can be decreased when combined with Indinavir.

INDINAVIR ANHYDROUS


The metabolism of Triamcinolone can be decreased when combined with Indinavir.

Indobufen


The risk or severity of adverse effects can be increased when Indobufen is combined with Triamcinolone.

Indomethacin


The risk or severity of adverse effects can be increased when Indomethacin is combined with Triamcinolone.

Insulin Detemir


The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Triamcinolone.

Insulin Glargine


The therapeutic efficacy of Insulin Glargine can be decreased when used in combination with Triamcinolone.

insulin human, rDNA origin


The therapeutic efficacy of Insulin Human can be decreased when used in combination with Triamcinolone.

Insulin Lispro


The therapeutic efficacy of Insulin Lispro can be decreased when used in combination with Triamcinolone.

Insulin, Aspart Protamine, Human


The therapeutic efficacy of Insulin Aspart can be decreased when used in combination with Triamcinolone.

Insulin, Aspart, Human


The therapeutic efficacy of Insulin Aspart can be decreased when used in combination with Triamcinolone.

Insulin, Glulisine, Human


The therapeutic efficacy of Insulin Glulisine can be decreased when used in combination with Triamcinolone.

Insulin, Pork


The therapeutic efficacy of Insulin Pork can be decreased when used in combination with Triamcinolone.

Insulin, Protamine Lispro, Human


The therapeutic efficacy of Insulin Lispro can be decreased when used in combination with Triamcinolone.

Insulin, Regular, Pork


The therapeutic efficacy of Insulin Pork can be decreased when used in combination with Triamcinolone.

Isavuconazole


The serum concentration of Triamcinolone can be increased when it is combined with Isavuconazole.

Isavuconazonium


The metabolism of Triamcinolone can be decreased when combined with Isavuconazonium.

Isoflurophate


The risk or severity of adverse effects can be increased when Triamcinolone is combined with Isoflurophate.

Isoniazid


The serum concentration of Isoniazid can be decreased when it is combined with Triamcinolone.

Isradipine


The metabolism of Triamcinolone can be decreased when combined with Isradipine.

Itraconazole


The metabolism of Triamcinolone can be decreased when combined with Itraconazole.

Ivacaftor


The serum concentration of Triamcinolone can be increased when it is combined with Ivacaftor.

Kebuzone


The risk or severity of adverse effects can be increased when Kebuzone is combined with Triamcinolone.

Ketoconazole


The metabolism of Triamcinolone can be decreased when combined with Ketoconazole.

Ketoprofen


The risk or severity of adverse effects can be increased when Ketoprofen is combined with Triamcinolone.

Ketorolac


The risk or severity of adverse effects can be increased when Ketorolac is combined with Triamcinolone.

Lacidipine


The serum concentration of Lacidipine can be decreased when it is combined with Triamcinolone.

Leflunomide


The risk or severity of adverse effects can be increased when Triamcinolone is combined with Leflunomide.

Levofloxacin


The risk or severity of adverse effects can be increased when Triamcinolone is combined with Levofloxacin.

Levofloxacin Anhydrous


The risk or severity of adverse effects can be increased when Triamcinolone is combined with Levofloxacin.

Limonene, (+)-


The risk or severity of adverse effects can be increased when (4R)-limonene is combined with Triamcinolone.

Linagliptin


The therapeutic efficacy of Linagliptin can be decreased when used in combination with Triamcinolone.

Liraglutide


The therapeutic efficacy of Liraglutide can be decreased when used in combination with Triamcinolone.

Lopinavir


The metabolism of Triamcinolone can be decreased when combined with Lopinavir.

Lornoxicam


The risk or severity of adverse effects can be increased when Lornoxicam is combined with Triamcinolone.

Lovastatin


The metabolism of Triamcinolone can be decreased when combined with Lovastatin.

Loxoprofen


The risk or severity of adverse effects can be increased when Loxoprofen is combined with Triamcinolone.

Luliconazole


The serum concentration of Triamcinolone can be increased when it is combined with Luliconazole.

Lumacaftor


The metabolism of Triamcinolone can be increased when combined with Lumacaftor.

Magaldrate


The bioavailability of Triamcinolone can be decreased when combined with Magaldrate.

Magnesium Hydroxide


The bioavailability of Triamcinolone can be decreased when combined with Magnesium hydroxide.

Magnesium Oxide


The bioavailability of Triamcinolone can be decreased when combined with Magnesium oxide.

Magnesium Salicylate


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Triamcinolone.

Magnesium Trisilicate


The bioavailability of Triamcinolone can be decreased when combined with Magnesium Trisilicate.

Malathion


The risk or severity of adverse effects can be increased when Triamcinolone is combined with Malathion.

Masoprocol


The risk or severity of adverse effects can be increased when Masoprocol is combined with Triamcinolone.

Meclofenamate


The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Triamcinolone.

Meclofenamic Acid


The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Triamcinolone.

Mefenamic Acid


The risk or severity of adverse effects can be increased when Mefenamic acid is combined with Triamcinolone.

Mefloquine


The risk or severity of adverse effects can be increased when Triamcinolone is combined with Mefloquine.

Meloxicam


The risk or severity of adverse effects can be increased when Meloxicam is combined with Triamcinolone.

Memantine


The risk or severity of adverse effects can be increased when Triamcinolone is combined with Memantine.

Mesalamine


The risk or severity of adverse effects can be increased when Mesalazine is combined with Triamcinolone.

Mesterolone


Triamcinolone may increase the fluid retaining activities of Mesterolone.

Mestranol


The serum concentration of Triamcinolone can be increased when it is combined with Mestranol.

Metformin


The therapeutic efficacy of Metformin can be decreased when used in combination with Triamcinolone.

Methyclothiazide


Triamcinolone may increase the hypokalemic activities of Methyclothiazide.

Methyl Salicylate


The risk or severity of adverse effects can be increased when Methyl salicylate is combined with Triamcinolone.

Methyltestosterone


Triamcinolone may increase the fluid retaining activities of Methyltestosterone.

Metoclopramide


The risk or severity of adverse effects can be increased when Triamcinolone is combined with Metoclopramide.

Metolazone


Triamcinolone may increase the hypokalemic activities of Metolazone.

Mifepristone


The therapeutic efficacy of Triamcinolone can be decreased when used in combination with Mifepristone.

Miglitol


The therapeutic efficacy of Miglitol can be decreased when used in combination with Triamcinolone.

Miglustat


The therapeutic efficacy of Miglustat can be decreased when used in combination with Triamcinolone.

Minaprine


The risk or severity of adverse effects can be increased when Triamcinolone is combined with Minaprine.

Mitotane


The serum concentration of Triamcinolone can be decreased when it is combined with Mitotane.

Mivacurium


Mivacurium may increase the adverse neuromuscular activities of Triamcinolone.

MYCOPHENOLATE


The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Triamcinolone.

Mycophenolate Mofetil


The risk or severity of adverse effects can be increased when Mycophenolate mofetil is combined with Triamcinolone.

Mycophenolic Acid


The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Triamcinolone.

Nabumetone


The risk or severity of adverse effects can be increased when Nabumetone is combined with Triamcinolone.

Naftifine


The risk or severity of adverse effects can be increased when Naftifine is combined with Triamcinolone.

Nalidixic Acid


The risk or severity of adverse effects can be increased when Triamcinolone is combined with Nalidixic Acid.

Nandrolone


Triamcinolone may increase the fluid retaining activities of Nandrolone.

Nandrolone Decanoate


Triamcinolone may increase the fluid retaining activities of Nandrolone decanoate.

Naproxen


The risk or severity of adverse effects can be increased when Naproxen is combined with Triamcinolone.

Natalizumab


The risk or severity of adverse effects can be increased when Triamcinolone is combined with Natalizumab.

Nateglinide


The therapeutic efficacy of Nateglinide can be decreased when used in combination with Triamcinolone.

Nefazodone


The metabolism of Triamcinolone can be decreased when combined with Nefazodone.

Nelfinavir


The metabolism of Triamcinolone can be decreased when combined with Nelfinavir.

Neostigmine


The risk or severity of adverse effects can be increased when Triamcinolone is combined with Neostigmine.

Nepafenac


The risk or severity of adverse effects can be increased when Nepafenac is combined with Triamcinolone.

Netupitant


The serum concentration of Triamcinolone can be increased when it is combined with Netupitant.

Nevirapine


The metabolism of Triamcinolone can be increased when combined with Nevirapine.

Nicorandil


The risk or severity of adverse effects can be increased when Triamcinolone is combined with Nicorandil.

Niflumic Acid


The risk or severity of adverse effects can be increased when Niflumic Acid is combined with Triamcinolone.

Nilotinib


The metabolism of Triamcinolone can be decreased when combined with Nilotinib.

Nimesulide


The risk or severity of adverse effects can be increased when Nimesulide is combined with Triamcinolone.

Norfloxacin


The risk or severity of adverse effects can be increased when Triamcinolone is combined with Norfloxacin.

O-PHENANTHROLINE


The risk or severity of adverse effects can be increased when Triamcinolone is combined with 1,10-Phenanthroline.

Ocrelizumab


Ocrelizumab may increase the immunosuppressive activities of Triamcinolone.

Oenothera biennis seed extract


The risk or severity of adverse effects can be increased when Evening primrose oil is combined with Triamcinolone.

Olaparib


The metabolism of Triamcinolone can be decreased when combined with Olaparib.

Olopatadine


The risk or severity of adverse effects can be increased when Olopatadine is combined with Triamcinolone.

Olsalazine


The risk or severity of adverse effects can be increased when Olsalazine is combined with Triamcinolone.

Osimertinib


The serum concentration of Triamcinolone can be increased when it is combined with Osimertinib.

Oxandrolone


Triamcinolone may increase the fluid retaining activities of Oxandrolone.

Oxaprozin


The risk or severity of adverse effects can be increased when Oxaprozin is combined with Triamcinolone.

Oxymetholone


Triamcinolone may increase the fluid retaining activities of Oxymetholone.

Oxyphenbutazone


The risk or severity of adverse effects can be increased when Oxyphenbutazone is combined with Triamcinolone.

Palbociclib


The serum concentration of Triamcinolone can be increased when it is combined with Palbociclib.

Parecoxib


The risk or severity of adverse effects can be increased when Parecoxib is combined with Triamcinolone.

Parthenolide


The risk or severity of adverse effects can be increased when Parthenolide is combined with Triamcinolone.

Pefloxacin


The risk or severity of adverse effects can be increased when Triamcinolone is combined with Pefloxacin.

Pentobarbital


The metabolism of Triamcinolone can be increased when combined with Pentobarbital.

Phenformin


The therapeutic efficacy of Phenformin can be decreased when used in combination with Triamcinolone.

Phenobarbital


The metabolism of Triamcinolone can be increased when combined with Phenobarbital.

Phenylacetic Acid


The therapeutic efficacy of Phenylacetic acid can be decreased when used in combination with Triamcinolone.

Phenylbutazone


The risk or severity of adverse effects can be increased when Phenylbutazone is combined with Triamcinolone.

Phenylbutyrate


The therapeutic efficacy of Phenylbutyric acid can be decreased when used in combination with Triamcinolone.

Phenytoin


The metabolism of Triamcinolone can be increased when combined with Phenytoin.

Physostigmine


The risk or severity of adverse effects can be increased when Triamcinolone is combined with Physostigmine.

Pimecrolimus


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Triamcinolone.

Pioglitazone


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Triamcinolone.

Piretanide


Triamcinolone may increase the hypokalemic activities of Piretanide.

Pirfenidone


The risk or severity of adverse effects can be increased when Pirfenidone is combined with Triamcinolone.

Piroxicam


The risk or severity of adverse effects can be increased when Piroxicam is combined with Triamcinolone.

Piroxicam-Beta-Cyclodextrin


The risk or severity of adverse effects can be increased when Piroxicam is combined with Triamcinolone.

Polyestradiol Phosphate


The serum concentration of Triamcinolone can be increased when it is combined with Polyestradiol phosphate.

Polythiazide


Triamcinolone may increase the hypokalemic activities of Polythiazide.

Posaconazole


The metabolism of Triamcinolone can be decreased when combined with Posaconazole.

Pramlintide


The therapeutic efficacy of Pramlintide can be decreased when used in combination with Triamcinolone.

Primidone


The metabolism of Triamcinolone can be increased when combined with Primidone.

Promestriene


The serum concentration of Triamcinolone can be increased when it is combined with Promestriene.

Pyridostigmine


The risk or severity of adverse effects can be increased when Triamcinolone is combined with Pyridostigmine.

Pyridostigmine Bromide


The risk or severity of adverse effects can be increased when Triamcinolone is combined with Pyridostigmine.

Quinestrol


The serum concentration of Triamcinolone can be increased when it is combined with Quinestrol.

Quinethazone


Triamcinolone may increase the hypokalemic activities of Quinethazone.

Rabies Immune Globulin, Human


The risk or severity of adverse effects can be increased when Triamcinolone is combined with Human rabies virus immune globulin.

Rabies Virus Vaccine Flury-Lep Strain


The therapeutic efficacy of Rabies virus inactivated antigen, A can be decreased when used in combination with Triamcinolone.

Ranolazine


The metabolism of Triamcinolone can be decreased when combined with Ranolazine.

Rapacuronium


Rapacuronium may increase the adverse neuromuscular activities of Triamcinolone.

Regular Insulin, Human


The therapeutic efficacy of Insulin Human can be decreased when used in combination with Triamcinolone.

Repaglinide


The therapeutic efficacy of Repaglinide can be decreased when used in combination with Triamcinolone.

Resveratrol


The risk or severity of adverse effects can be increased when Resveratrol is combined with Triamcinolone.

Rifabutin


The metabolism of Triamcinolone can be increased when combined with Rifabutin.

Rifampin


The metabolism of Triamcinolone can be increased when combined with Rifampicin.

Rifapentine


The metabolism of Triamcinolone can be increased when combined with Rifapentine.

Ritonavir


The risk or severity of adverse effects can be increased when Ritonavir is combined with Triamcinolone.

Rivastigmine


The risk or severity of adverse effects can be increased when Triamcinolone is combined with Rivastigmine.

Rofecoxib


The risk or severity of adverse effects can be increased when Rofecoxib is combined with Triamcinolone.

Roflumilast


Roflumilast may increase the immunosuppressive activities of Triamcinolone.

Rosiglitazone


The therapeutic efficacy of Rosiglitazone can be decreased when used in combination with Triamcinolone.

Rosoxacin


The risk or severity of adverse effects can be increased when Triamcinolone is combined with Rosoxacin.

ROTAVIRUS VACCINE, LIVE


The risk or severity of adverse effects can be increased when Triamcinolone is combined with Rotavirus Vaccine.

Rubella Virus Vaccine Live (wistar Ra 27-3 Strain)


The risk or severity of adverse effects can be increased when Triamcinolone is combined with Rubella virus vaccine.

Rucaparib


The metabolism of Triamcinolone can be decreased when combined with Rucaparib.

Salicylamide


The risk or severity of adverse effects can be increased when Salicylamide is combined with Triamcinolone.

Salicylic Acid


The risk or severity of adverse effects can be increased when Salicylic acid is combined with Triamcinolone.

Salmonella enterica subsp. enterica serovar typhi


The risk or severity of adverse effects can be increased when Triamcinolone is combined with Salmonella typhi ty21a live antigen.

Salsalate


The risk or severity of adverse effects can be increased when Salsalate is combined with Triamcinolone.

Saquinavir


The metabolism of Triamcinolone can be decreased when combined with Saquinavir.

Saquinavir Mesylate


The metabolism of Triamcinolone can be decreased when combined with Saquinavir.

Sarilumab


The therapeutic efficacy of Triamcinolone can be decreased when used in combination with Sarilumab.

Saxagliptin


The therapeutic efficacy of Saxagliptin can be decreased when used in combination with Triamcinolone.

Saxagliptin Anhydrous


The therapeutic efficacy of Saxagliptin can be decreased when used in combination with Triamcinolone.

Serratiopeptidase


The risk or severity of adverse effects can be increased when Serrapeptase is combined with Triamcinolone.

Sildenafil


The metabolism of Triamcinolone can be decreased when combined with Sildenafil.

Siltuximab


The serum concentration of Triamcinolone can be decreased when it is combined with Siltuximab.

Simeprevir


The serum concentration of Triamcinolone can be increased when it is combined with Simeprevir.

sipuleucel-T


The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Triamcinolone.

Sitagliptin


The therapeutic efficacy of Sitagliptin can be decreased when used in combination with Triamcinolone.

Sitagliptin Phosphate


The therapeutic efficacy of Sitagliptin can be decreased when used in combination with Triamcinolone.

Sodium Bicarbonate


The bioavailability of Triamcinolone can be decreased when combined with Sodium bicarbonate.

Sparfloxacin


The risk or severity of adverse effects can be increased when Triamcinolone is combined with Sparfloxacin.

ST. JOHN'S WORT EXTRACT


The serum concentration of Triamcinolone can be decreased when it is combined with St. John's Wort.

Stanozolol


Triamcinolone may increase the fluid retaining activities of Stanozolol.

Sulfasalazine


The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Triamcinolone.

Sulfisoxazole


The metabolism of Triamcinolone can be decreased when combined with Sulfisoxazole.

Sulindac


The risk or severity of adverse effects can be increased when Sulindac is combined with Triamcinolone.

Suprofen


The risk or severity of adverse effects can be increased when Suprofen is combined with Triamcinolone.

synthetic conjugated estrogens, A


The serum concentration of Triamcinolone can be increased when it is combined with Synthetic Conjugated Estrogens, A.

synthetic conjugated estrogens, B


The serum concentration of Triamcinolone can be increased when it is combined with Synthetic Conjugated Estrogens, B.

Tacrine


The risk or severity of adverse effects can be increased when Triamcinolone is combined with Tacrine.

Tacrolimus


Tacrolimus may increase the immunosuppressive activities of Triamcinolone.

Telaprevir


The serum concentration of Telaprevir can be decreased when it is combined with Triamcinolone.

Telithromycin


The metabolism of Triamcinolone can be decreased when combined with Telithromycin.

Temafloxacin


The risk or severity of adverse effects can be increased when Triamcinolone is combined with Temafloxacin.

Tenoxicam


The risk or severity of adverse effects can be increased when Tenoxicam is combined with Triamcinolone.

Teriflunomide


The risk or severity of adverse effects can be increased when Teriflunomide is combined with Triamcinolone.

Testosterone


Triamcinolone may increase the fluid retaining activities of Testosterone.

Testosterone Cypionate


Triamcinolone may increase the fluid retaining activities of Testosterone cypionate.

Testosterone Enanthate


Triamcinolone may increase the fluid retaining activities of Testosterone enanthate.

Testosterone Propionate


Triamcinolone may increase the fluid retaining activities of Testosterone propionate.

Testosterone Undecanoate


Triamcinolone may increase the fluid retaining activities of Testosterone undecanoate.

Tetanus Toxoid Vaccine, Inactivated


The risk or severity of adverse effects can be increased when Triamcinolone is combined with Clostridium tetani toxoid antigen (formaldehyde inactivated).

Tiaprofenic Acid


The risk or severity of adverse effects can be increased when Tiaprofenic acid is combined with Triamcinolone.

Tibolone


The serum concentration of Triamcinolone can be increased when it is combined with Tibolone.

Ticlopidine


The metabolism of Triamcinolone can be decreased when combined with Ticlopidine.

Tocilizumab


The serum concentration of Triamcinolone can be decreased when it is combined with Tocilizumab.

Tofacitinib


Triamcinolone may increase the immunosuppressive activities of Tofacitinib.

Tolazamide


The therapeutic efficacy of Tolazamide can be decreased when used in combination with Triamcinolone.

Tolbutamide


The therapeutic efficacy of Tolbutamide can be decreased when used in combination with Triamcinolone.

Tolfenamic Acid


The risk or severity of adverse effects can be increased when Tolfenamic Acid is combined with Triamcinolone.

Tolmetin


The risk or severity of adverse effects can be increased when Tolmetin is combined with Triamcinolone.

Torsemide


Triamcinolone may increase the hypokalemic activities of Torasemide.

Tranilast


The risk or severity of adverse effects can be increased when Tranilast is combined with Triamcinolone.

Trastuzumab


Trastuzumab may increase the neutropenic activities of Triamcinolone.

Trichlormethiazide


Triamcinolone may increase the hypokalemic activities of Trichlormethiazide.

Troglitazone


The therapeutic efficacy of Troglitazone can be decreased when used in combination with Triamcinolone.

Trolamine Salicylate


The risk or severity of adverse effects can be increased when Trolamine salicylate is combined with Triamcinolone.

Tromethamine


The bioavailability of Triamcinolone can be decreased when combined with Tromethamine.

Trovafloxacin


The risk or severity of adverse effects can be increased when Triamcinolone is combined with Trovafloxacin.

Tubocurarine


The risk or severity of adverse effects can be increased when Triamcinolone is combined with Tubocurarine.

Typhoid Vaccine Live Ty21a


The risk or severity of adverse effects can be increased when Triamcinolone is combined with Salmonella typhi ty21a live antigen.

Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain


The risk or severity of adverse effects can be increased when Triamcinolone is combined with Salmonella typhi ty2 vi polysaccharide antigen.

Valdecoxib


The risk or severity of adverse effects can be increased when Valdecoxib is combined with Triamcinolone.

Varicella Virus Vaccine Live (Oka-Merck) strain


The risk or severity of adverse effects can be increased when Triamcinolone is combined with Varicella Zoster Vaccine (Live/Attenuated).

Vemurafenib


The serum concentration of Triamcinolone can be decreased when it is combined with Vemurafenib.

Venlafaxine


The metabolism of Triamcinolone can be decreased when combined with Venlafaxine.

Verapamil


The metabolism of Triamcinolone can be decreased when combined with Verapamil.

Vildagliptin


The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Triamcinolone.

Voriconazole


The metabolism of Triamcinolone can be decreased when combined with Voriconazole.

Warfarin


Triamcinolone may increase the anticoagulant activities of Warfarin.

Yellow Fever Vaccine


The risk or severity of adverse effects can be increased when Triamcinolone is combined with Yellow Fever Vaccine.

Yellow-Fever Virus Vaccine, 17D-204 strain


The risk or severity of adverse effects can be increased when Triamcinolone is combined with Yellow Fever Vaccine.

Zileuton


The risk or severity of adverse effects can be increased when Zileuton is combined with Triamcinolone.

Ziprasidone


The metabolism of Triamcinolone can be decreased when combined with Ziprasidone.

Zomepirac


The risk or severity of adverse effects can be increased when Zomepirac is combined with Triamcinolone.

Advertisement
Drugs A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
How to Live Longer and Healthier: Secrets of Longevity Revealed
Stay Connected
Available on the Android Market Available on the App Store